American CryoStem Corporation is a developer and marketer of adipose tissue-based cellular technologies and related services. The Company focuses on clinical processing, commercial bio-banking and application development of cellular tools and applications using autologous adipose (fat) tissue and adipose derived stem cells (ADSCs). The Company's products and services include CELLECT, ATGRAFT, ATCELL, ACSELERATE, ACS Laboratories and International Licensing. The Company is in the business of collecting adipose tissue, processing it to separate the adult stem cells, and preparing such stem cells for long-term storage. Its ATGRAFT procedures include breast reconstruction, layered augmentation, buttocks enhancement or volume corrections of the hands, feet, face and neck areas. Its ACSelerate product is engaged in manufacturing various versions of its ACSelerate cell culture media, which include ACSelerate-MAX, ACSelerate-SFM, ACSelerate-CY, ACSelerate-MY, ACSelerate-CP and ACSelerate- TR.